ASCO Statement on the Passage of the Patient Protection and Affordable Health Care Act

ASCO SIGN IN

Manage Email Subscriptions

Username:

Create an account

Why Be A Member?

Password:

Remember me

Forgot your username or password?

ASCO Membership Directory

The Remember Me feature is an automatic login process which creates a cookie on the hard drive of your computer containing a unique identifier which ASCO.org will utilize to remember you by, thereby avoiding the need to enter username and password upon subsequent visits to ASCO.org. DO NOT select this option if you share this computer with others since transactional, personal, or member only information will be accessible by other users.

To activate the Remember Me option, click the empty check box when signing in to the site. The Remember Me functionality is deactivated at the logout.

For additional information please review our Privacy Policy.

ASCO Home

Press Center

ASCO Statement on the Passage of the Patient Protection and Affordable Health Care Act

CONTACT: Amanda Stanley
571-483-1364
amanda.stanley@asco.org

While ASCO recognizes that there are strong feelings on both sides of this issue, we are very pleased that the newly passed Patient Protection and Affordable Care Act signed into law this week includes a number of things that will benefit cancer patients in the short term and the long term. However, we also recognize that there is still a lot of work to be done, and we will continue our advocacy on those additional fronts.

ASCO is most pleased that the legislation includes guaranteed insurance coverage for individuals participating in clinical trials. ASCO has been at the forefront of this issue for nearly two decades. Clinical trials remain the cornerstone of cancer research, and are often the patient’s best option. Under the new federal law, patients can now afford to participate.

ASCO also supports closing the drug prescription gap in Medicare Part D. As more and more cancer drugs become available in oral form, the drugs have become less affordable for cancer patients. Beginning in 2010, seniors who fall in the “doughnut hole,” or, spend between $2,700 and $6,154, will receive a $250 government subsidy to help cover the costs of their medication. By 2020, Medicare will cover 75 percent of drug costs in the “doughnut hole” for Medicare patients.

The removal of lifetime caps on insurance coverage is also a step forward for cancer patients. Many cancer patients who need repeated courses of treatment can easily exceed their caps and find themselves unable to afford needed treatment and medication. ASCO looks forward to seeing the financial burdens often associated with cancer treatment ease under this new federal policy.

Children with cancer will also benefit from the legislation. In just six months, insurers will no longer be able to exclude children with pre-existing conditions from being covered by their family policy. For current policies, that means insurance companies must rescind pre-existing condition exclusions. ASCO is also pleased that dependent children up to age 26 will be able to remain on their parents’ family policy effective immediately.

While ASCO supports improved access to healthcare for millions of Americans, uninsured cancer patients still won’t have sufficient coverage. These patients cannot afford to wait. ASCO is ready to work with policymakers and the Obama Administration in order to fill this urgent gap.

ASCO is also deeply concerned that the legislation does not address the flawed Sustainable Growth Rate. Oncology practices are struggling to survive, and ASCO urges a permanent repeal of the SGR. The temporary patches implemented in the past are no longer a viable solution. The SGR could potentially cause devastating cuts that will negatively impact cancer patients and practices; immediate action must be taken.

ASCO, representing more than 28,000 oncologists, will continue to support public policy that ensures patient access to high-quality cancer care and supports increased clinical cancer research.